News Articles | Pfizer Singapore

Biopharma Leaders Unite To Stand With Science

Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19

Alibaba Cloud, Fintech Academy and Pfizer Partner to Accelerate Healthcare Innovations

LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer

RECENT PRESS RELEASES

22/06/2020 - European Medicines Agency Validates Application for BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

22/06/2020 - Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines

18/06/2020 - Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy

18/06/2020 - Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn

16/06/2020 - Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts

12/06/2020 - Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th

11/06/2020 - FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf)

10/06/2020 - Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis

03/06/2020 - Complete Results from Second Pivotal Monotherapy Study of Abrocitinib Published in JAMA Dermatology

02/06/2020 - Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

02/06/2020 - Pfizer Establishes New Program to Support Continued Biotechnology Innovation

29/05/2020 - Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer

29/05/2020 - Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer

22/05/2020 - Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC

19/05/2020 - Pfizer Prices $4,000,000,000 Debt Offering